07 Jan 2001

ISDN-ratiopharm® 5; (ISDN-ratiopharm® 5 Tabletten) - Deutschland

Updated: 07 Jan 2001

ISDN-ratiopharm® 5; -20 | -40 | -60 | -80

ISDN-ratiopharm 5: Sublinguale Appl.: akuter Angina-pectoris-Anfall. ISDN-ratiopharm 20/40/60/80 mg: Prophylaxe u. Langzeitther. d. Angina pectoris. Ther. d. schweren chron. Herzinsuffizienz b. gleichz. Gabe v. Herzglykosiden, Diuretika, ACE-Hemmern, arteriellen Vasodilatatoren. Pulmonale Hypertonie.

ISDN-ratiopharm® 5; Description, Presentation and Dosage

ISDN-ratiopharm® 5; Description

ISDN-ratiopharm® 5; Drug Class Description

Andere Nitrate

ISDN-ratiopharm® 5; Drug Description

1 Tbl. enth.: Isosorbiddinitrat 5 mg.

ISDN-ratiopharm® 5; Generic Name

ISDN-ratiopharm® 5 Tabletten

ISDN-ratiopharm® 5; Presentation

ISDN-ratiopharm® 5; Presentation

ISDN-ratiopharm® 5; -20/-40/-60/-80

ISDN-ratiopharm® 5; Manufacturer

ratiopharm

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

ISDN-ratiopharm® 5; Dosage

ISDN-ratiopharm® 5; Adult Dosage

D-Mannitol, Maisstärke, Lactose 1H2O, Mikrokristalline Cellulose, Siliciumdioxid, Copolyvidon, Talkum, Magnesiumstearat, Natriumcyclamat. trimethylammonioethyl)methacrylatchlorid], Triethylcitrat, Lactose 1H2O, Farbstoffe E 171, E 172, 20 mg/40 mg zusätzlich: Saccharose, Maisstärke, Gelatine.

ISDN-ratiopharm® 5; Child Dosage


ISDN-ratiopharm® 20/-40/-60/-80 Retardkapseln
Zus.: 1 Retardkps. enth.: Isosorbiddinitrat 20 mg/40 mg/60 mg/80 mg.
Weit. Bestandteile: Mikrokristalline Cellulose, Carmellose-Natrium, Poly(O-2-hydroxypropyl, O-methyl)cellulose, Siliciumdioxid, Poly[ethylacrylat-co-methylmethacrylat-co- (2-

ISDN-ratiopharm® 5; Precautions, Reactions and Contraindications

ISDN-ratiopharm® 5; Special Precautions

ISDN-ratiopharm® 5; Special Precautions

N 40 a-d

ISDN-ratiopharm® 5; Adverse Reactions

ISDN-ratiopharm® 5; Adverse Reactions

N 40

Related Drugs - Angiology

Back to top